Literature DB >> 9311583

Constitutive co-expression of estrogen and progesterone receptor mRNA in human meningiomas by RT-PCR and response of in vitro cell cultures to steroid hormones.

V Speirs1, E Boyle-Walsh, W D Fraser.   

Abstract

Although it is well recognised that human meningiomas are rich in progesterone receptor (PgR), controversy has existed about the presence of the estrogen receptor (ER) in these tumours. We have investigated the presence of both ER and PgR in a series of 20 human meningiomas, spanning the main histological groups, using reverse transcription linked PCR (RT-PCR). Total RNA was extracted from whole tissues and reverse transcribed to yield cDNA. This was amplified using primers specifically designed to detect ER and PgR. All samples co-expressed ER and PgR mRNA, irrespective of tumour classification, patient age or sex. In general, transcripts for PgR appeared considerably stronger than those for ER, and although this was a purely qualitative study, it suggests increased expression of PgR. Addition of exogenous 17beta-estradiol or progesterone to meningioma cell cultures showed that 2/4 cultures responded to these steroids. Our results confirm that human meningiomas do express gene transcripts for ER, and that previous failures to detect ER in these tumours may be due to the lack of sensitivity of the techniques employed. However, these receptors may not be functional in all tumours.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9311583     DOI: 10.1002/(sici)1097-0215(19970904)72:5<714::aid-ijc2>3.0.co;2-v

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

Review 1.  VEGF in brain tumors.

Authors:  M R Machein; K H Plate
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

2.  The relationship between urinary bisphenol A levels and meningioma in Chinese adults.

Authors:  Bo Duan; Xuebin Hu; Hongyang Zhao; Jun Qin; Jie Luo
Journal:  Int J Clin Oncol       Date:  2012-04-25       Impact factor: 3.402

3.  Pathophysiology of Meningioma Growth in Pregnancy.

Authors:  Tibor Hortobágyi; János Bencze; Balázs Murnyák; Mahan C Kouhsari; László Bognár; György Marko-Varga
Journal:  Open Med (Wars)       Date:  2017-07-13

4.  Body mass index and the risk of meningioma, glioma and schwannoma in a large prospective cohort study (The HUNT Study).

Authors:  M Wiedmann; C Brunborg; K Lindemann; T B Johannesen; L Vatten; E Helseth; J A Zwart
Journal:  Br J Cancer       Date:  2013-06-18       Impact factor: 7.640

Review 5.  Molecular Genetics of Intracranial Meningiomas with Emphasis on Canonical Wnt Signalling.

Authors:  Nives Pećina-Šlaus; Anja Kafka; Mirna Lechpammer
Journal:  Cancers (Basel)       Date:  2016-07-15       Impact factor: 6.639

6.  Estrogen hormone replacement therapy in incidental intracranial meningioma: a growth-rate analysis.

Authors:  Laura Dresser; Ryan T Merrell; David Olayinka Kamson; Carlen Amy Yuen; Andrew Wilmington; Matthew Walker; Tilley Jenkins Vogel
Journal:  Sci Rep       Date:  2020-10-21       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.